Tata Elxsi has launched ViTel, a Material Intelligence solution for medical device manufacturers co-developed with Viridium AI. The solution aims to help manufacturers protect margins, accelerate sourcing and engineering decisions, and stay ahead of compliance through AI-powered material intelligence. ViTel is being formally introduced at DeviceTalks Boston 2026.

Medical device manufacturers face challenges where material decisions affect margin, resilience, product velocity, and market access. Critical product knowledge is often buried across BOMs, supplier documents, ERP and PLM systems, and expert teams. This fragmentation makes every new regulation or customer requirement a costly manual exercise.

ViTel addresses this by creating a reusable Material Intelligence layer across the enterprise. It helps teams identify material and supplier dependencies, assess country-of-origin and sourcing exposure, evaluate alternatives, and understand where product or material risks affect cost, continuity, or market access. The solution is powered by Viridium AI's Knowledge Cloud, Chemical Digital Twin, and science-constrained AI models.

The solution transforms scattered enterprise data into a living product-material knowledge graph connecting products, parts, materials, chemicals, suppliers, regulations, and evidence. ViTel draws on tata elxsi 's three decades of Med-Tech engineering and regulatory expertise. This knowledge has been embedded into how the solution reasons about material risk, compliance, and sourcing decisions.

Sreevatsa Sahasranaman, Senior Vice President and Head, Healthcare and Life Sciences, Tata Elxsi, stated that ViTel brings Material Intelligence directly into product and compliance workflows. He noted that this helps customers make faster, more confident decisions across sourcing, engineering, quality, and regulatory readiness.

Niraj Deo, Chief Executive Officer, Viridium AI, said the company was built to help manufacturers understand the material DNA of their products. He added that digitizing product and material knowledge creates a reusable enterprise asset for margin, sourcing, engineering, quality, and regulatory decisions.

ViTel is co-developed through STEP UP, Tata Elxsi's co-innovation program for high-potential deep-tech companies. Muthusamy Selvaraj, VP, Innovation and Partnerships, Healthcare and Life Sciences, Tata Elxsi, emphasized that the partnership ensures accountability for the outcome.

Tata Elxsi Limited has informed its shareholders regarding the tax deduction at source (TDS) applicable to the final dividend declared for the financial year ended March 31, 2026. The Board of Directors recommended a dividend of ₹75 per equity share of ₹10 each, payable following shareholder approval at the 37th Annual General Meeting scheduled for June 2026.

Tax Deduction Provisions

Under the Income Tax Act, 2025, dividend income is taxable in the hands of shareholders. Consequently, the company is required to deduct TDS at applicable rates. For resident shareholders, TDS under Section 393(1) will be deducted at 10% on the dividend amount exceeding ₹10,000, unless an exemption applies. Shareholders must ensure their Permanent Account Number (PAN) is valid and linked with Aadhaar; failure to do so will result in a higher TDS rate of 20%.

Documentation Requirements

Shareholders eligible for exemption or lower withholding tax must submit specific forms and documents. Resident individuals wishing to receive dividend without TDS deduction must file Form 121. Institutional shareholders, such as insurance companies and mutual funds, are required to submit declarations confirming their exemption status under relevant schedules of the Income Tax Act.

Non-Resident Shareholders

Non-resident shareholders can avail benefits under Double Tax Avoidance Agreements (DTAA) by providing a Tax Residency Certificate (TRC) for the tax year 2026-27, Form 41, and a copy of their PAN card. Additionally, self-declarations regarding beneficial ownership and the absence of a permanent establishment in India are mandatory.

Submission Deadlines

All tax-related documents must be submitted by June 10, 2026, before 06:00 p.m. IST. Documents can be uploaded via the specified link or emailed to the designated address. Communications received after the deadline will not be considered, potentially resulting in tax deduction at higher rates.

Shareholders are advised to update their bank account details and ensure KYC compliance for physical shareholdings to facilitate timely dividend payments.